Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM News Today.
July 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
August 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | ||||
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | 30 | 31 |
September 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 |
Press releases published on August 29, 2025
Press Release: Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia
GlobeNewswire
·
August 29, 2025
Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia Novel treatment targets BTK through multi-immune modulation to help address root causes of ITP Approval based on LUNA 3 phase 3 study that demonstrated rapid and durable …
Communiqué de presse : Wayrilz de Sanofi est approuvé aux États-Unis comme premier inhibiteur de BTK pour la thrombocytopénie immune
GlobeNewswire
·
August 29, 2025
Wayrilz de Sanofi est approuvé aux États-Unis comme premier inhibiteur de BTK pour la thrombocytopénie immune Ce traitement novateur cible la tyrosine kinase de Bruton (BTK) par une modulation multi-immune pour aider à traiter les causes profondes de la …
Warwickshire Welcomes Fast-Track Urology Clinic as Mr Haider Syed Brings Expert Care Close to Home
EIN Presswire
·
August 29, 2025
Solihull clinic offers same-week urology care, including treatment for kidney stones and urinary infections, swiftly and expertly handled by Mr Haider Syed. WARWICK, WARWICKSHIRE, UNITED KINGDOM, August 29, 2025 /EINPresswire.com/ -- In a welcome …
Northland Announces Reset Dividend Rate on Its Cumulative Rate Reset Preferred Shares, Series 1 & Series 2
GlobeNewswire
·
August 29, 2025
TORONTO, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Northland Power Inc. ("Northland" or the "Company") (TSX: NPI) today announced that pursuant to the share terms in respect of the Cumulative Rate Reset Preferred Shares, Series 1 (“Series 1 Shares”), it has …
Biomerica Reports Fiscal 2025 Year End Results
GlobeNewswire
·
August 29, 2025
$1.3 Million in Operating Expense Reductions Achieved– Operating Loss Improves 19% Year-Over-Year Resilient Portfolio Performance with International Sales Despite Global Economic Uncertainties Cash Used in Operating Activities Reduced to $3.8 Million vs. $ …
Corey Barss Named VP of Operations as FIELDBOSS Expands Leadership to Support Contractor Growth in HVAC and Elevator Markets
GlobeNewswire
·
August 29, 2025
Toronto, Ontario, Aug. 29, 2025 (GLOBE NEWSWIRE) -- FIELDBOSS, the all-in-one field service management platform built for HVAC, elevator, and specialty contractors, today announced the promotion of Corey Barss to Vice President of Operations. The …
Newcore Gold Announces Annual Grant of Equity Incentive Awards
GlobeNewswire
·
August 29, 2025
VANCOUVER, British Columbia, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Newcore Gold Ltd. ("Newcore" or the "Company") (TSX-V: NCAU, OTCQX: NCAUF) announces the annual grant of equity incentive awards. Newcore has granted 2,815,000 stock options, 1,880,000 …
Helium Evolution Closes $8.3 Million Convertible Note and Announces Q2-2025 Results
GlobeNewswire
·
August 29, 2025
CALGARY, Alberta, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Helium Evolution Incorporated (TSXV:HEVI) ("HEVI" or the "Company"), a Canadian-based helium exploration company focused on developing assets in southern Saskatchewan, is pleased to announce the closing …
FDA Approves LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer's Disease
GlobeNewswire
·
August 29, 2025
LEQEMBI IQLIK is the first and only anti-amyloid treatment to offer an at-home injection to help patients and care partners continue to treat this progressive, relentless disease after initial treatment of 18 months LEQEMBI IQLIK will be launched on …
Scheffler Bausanierung Launches in Frankfurt with a Fresh Approach to Renovation & Construction
GlobeNewswire
·
August 29, 2025
Hofheim, Frankfurt, Aug. 29, 2025 (GLOBE NEWSWIRE) -- A new name is making waves in the German construction and renovation industry. Scheffler Bausanierung, under the leadership of owner Dorela Scheffler, has officially launched in Hofheim, Frankfurt am …
Pan American Announces LIFE Offering and Concurrent Private Placement Offering
GlobeNewswire
·
August 29, 2025
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pan American Energy Corp. (the “Company” or “Pan American”) (CSE: PNRG) (OTCQB: PAANF) (FRA: SS6) …
Mine Permit Received Approving Mount Polley’s Life of Mine Plan
GlobeNewswire
·
August 29, 2025
VANCOUVER, British Columbia, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Imperial Metals Corporation (the “Company” or “Imperial”) (TSX:III) reports that the Province of British Columbia has issued a permit amendment to allow expansion and extension of mining …
Kyivstar Rings Opening Bell at Nasdaq Marking Landmark Listing and Highlighting Ukraine’s Investment Case
GlobeNewswire
·
August 29, 2025
New York – August 29, 2025 – VEON Ltd. (Nasdaq: VEON) (“VEON), a global digital operator and parent company of Ukraine’s leading digital operator Kyivstar Group Ltd (Nasdaq: KYIV; KYIVW) (“Kyivstar”), today rang the opening bell on Nasdaq Stock Market (“ …
Edward H. Baine Elected to the Hubbell Incorporated Board of Directors
GlobeNewswire
·
August 29, 2025
Shelton, CT, Aug. 29, 2025 (GLOBE NEWSWIRE) -- EDWARD H. BAINE ELECTED TO THE HUBBELL INCORPORATED BOARD OF DIRECTORS The Board of Directors of Hubbell Incorporated (NYSE: HUBB) announced today the election of Edward H. Baine as a Director of the company …
DIH Holding US, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
GlobeNewswire
·
August 29, 2025
NORWELL, Mass., Aug. 29, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. (“DIH” or the “Company”) (NASDAQ:DHAI) received a notice on August 26, 2025, from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”), which stated that the …
reAlpha to Present at the 27th Annual H.C. Wainwright Global Investment Conference in New York
GlobeNewswire
·
August 29, 2025
DUBLIN, Ohio, Aug. 29, 2025 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (Nasdaq: AIRE) (“reAlpha” or the “Company”), an AI-powered real estate technology company, today announced that Chief Executive Officer Mike Logozzo and Chief Financial Officer Piyush …
Hubbell to Participate in Upcoming Investor Conference
GlobeNewswire
·
August 29, 2025
Shelton, CT, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Hubbell Incorporated (NYSE: HUBB) today announced that Bill Sperry, Chief Financial Officer, will appear at the Morgan Stanley 2025 Laguna Conference. The event will be webcast and is scheduled to begin at 4: …
Acceleware Ltd. Reports Second Quarter 2025 Financial and Operating Results
GlobeNewswire
·
August 29, 2025
CALGARY, Alberta, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Acceleware® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), Acceleware is a leading innovator of cutting-edge radio frequency (“RF”) power-to-heat technologies targeting process heat for critical …
Locafy Reports Fiscal Nine-Month 2025 Results and Highlights Operational Progress, Positioning the Company to Scale
GlobeNewswire
·
August 29, 2025
- Expanded U.S. footprint through strategic partnerships and enterprise wins - Delivered AI-powered product innovations enabling rapid market adoption - Partner-led go-to-market model positioned for accelerated growth PERTH, Australia, Aug. 29, 2025 (GLOBE …
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 29, 2025
VANCOUVER, British Columbia and BOSTON, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing …